These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 19124613

  • 1. Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding.
    Gkountelias K, Tselios T, Venihaki M, Deraos G, Lazaridis I, Rassouli O, Gravanis A, Liapakis G.
    Mol Pharmacol; 2009 Apr; 75(4):793-800. PubMed ID: 19124613
    [Abstract] [Full Text] [Related]

  • 2. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
    Hoare SR, Sullivan SK, Schwarz DA, Ling N, Vale WW, Crowe PD, Grigoriadis DE.
    Biochemistry; 2004 Apr 06; 43(13):3996-4011. PubMed ID: 15049707
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Exploring the binding site crevice of a family B G protein-coupled receptor, the type 1 corticotropin releasing factor receptor.
    Gkountelias K, Papadokostaki M, Javitch JA, Liapakis G.
    Mol Pharmacol; 2010 Oct 06; 78(4):785-93. PubMed ID: 20664003
    [Abstract] [Full Text] [Related]

  • 5. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE, Liu XJ, Vaughn J, Palmer SF, True CD, Vale WW, Ling N, De Souza EB.
    Mol Pharmacol; 1996 Sep 06; 50(3):679-86. PubMed ID: 8794910
    [Abstract] [Full Text] [Related]

  • 6. Extracellular cysteines of the corticotropin-releasing factor receptor are critical for ligand interaction.
    Qi LJ, Leung AT, Xiong Y, Marx KA, Abou-Samra AB.
    Biochemistry; 1997 Oct 14; 36(41):12442-8. PubMed ID: 9376348
    [Abstract] [Full Text] [Related]

  • 7. Impact of N-terminal domains for corticotropin-releasing factor (CRF) receptor-ligand interactions.
    Klose J, Fechner K, Beyermann M, Krause E, Wendt N, Bienert M, Rudolph R, Rothemund S.
    Biochemistry; 2005 Feb 08; 44(5):1614-23. PubMed ID: 15683245
    [Abstract] [Full Text] [Related]

  • 8. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
    Hoare SR, Sullivan SK, Fan J, Khongsaly K, Grigoriadis DE.
    Peptides; 2005 Mar 08; 26(3):457-70. PubMed ID: 15652653
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain.
    Beyermann M, Heinrich N, Fechner K, Furkert J, Zhang W, Kraetke O, Bienert M, Berger H.
    Br J Pharmacol; 2007 Jul 08; 151(6):851-9. PubMed ID: 17533422
    [Abstract] [Full Text] [Related]

  • 13. Determinants of corticotropin releasing factor. Receptor selectivity of corticotropin releasing factor related peptides.
    Mazur AW, Wang F, Tscheiner M, Donnelly E, Isfort RJ.
    J Med Chem; 2004 Jun 17; 47(13):3450-4. PubMed ID: 15189041
    [Abstract] [Full Text] [Related]

  • 14. Sauvagine analogs selective for corticotropin releasing factor 2 receptor: effect of substitutions at positions 35 and 39 on CRF2R selectivity.
    Mazur AW, Wang F, Tscheiner M, Donnelly E, Isfort RJ.
    Peptides; 2005 May 17; 26(5):887-91. PubMed ID: 15808919
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Localization of agonist- and antagonist-binding domains of human corticotropin-releasing factor receptors.
    Liaw CW, Grigoriadis DE, Lorang MT, De Souza EB, Maki RA.
    Mol Endocrinol; 1997 Dec 17; 11(13):2048-53. PubMed ID: 9415408
    [Abstract] [Full Text] [Related]

  • 18. Juxtamembrane region of the amino terminus of the corticotropin releasing factor receptor type 1 is important for ligand interaction.
    Assil IQ, Qi LJ, Arai M, Shomali M, Abou-Samra AB.
    Biochemistry; 2001 Feb 06; 40(5):1187-95. PubMed ID: 11170443
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.